Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.45T | 2.38T | 2.27T | 2.10T | 2.01T | 1.91T | Gross Profit |
622.30B | 593.13B | 526.68B | 450.44B | 397.92B | 469.74B | EBIT |
430.38B | 339.69B | 305.40B | 244.98B | 203.77B | 280.62B | EBITDA |
469.06B | 473.42B | 476.69B | 405.51B | 301.97B | 372.05B | Net Income Common Stockholders |
203.81B | 224.65B | 197.00B | 176.99B | 129.58B | 183.97B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
288.97B | 189.81B | 144.26B | 156.23B | 199.64B | 190.31B | Total Assets |
9.66T | 9.49T | 8.84T | 8.21T | 7.74T | 7.40T | Total Debt |
4.74T | 4.43T | 4.05T | 3.67T | 3.62T | 3.48T | Net Debt |
4.46T | 4.25T | 3.91T | 3.52T | 3.43T | 3.30T | Total Liabilities |
6.47T | 6.25T | 5.81T | 5.29T | 5.09T | 4.91T | Stockholders Equity |
3.07T | 3.11T | 2.90T | 2.80T | 2.56T | 2.41T |
Cash Flow | Free Cash Flow | ||||
134.85B | 20.86B | -65.04B | 29.90B | -88.47B | -386.72B | Operating Cash Flow |
134.85B | 241.70B | 297.71B | 271.47B | 187.86B | 87.09B | Investing Cash Flow |
0.00 | -286.99B | -422.03B | -210.06B | -131.03B | -532.81B | Financing Cash Flow |
0.00 | 59.99B | 111.45B | -139.60B | -66.56B | 467.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $23.73B | 18.50 | 6.51% | 1.63% | -6.74% | -13.89% | |
76 Outperform | $62.32B | 22.67 | 80.78% | 4.90% | 5.40% | 8.57% | |
64 Neutral | $14.56B | 944.18 | 1.32% | 1.94% | -1.30% | -80.81% | |
61 Neutral | $4.74B | 19.16 | -3.00% | 7.93% | 6.45% | -20.78% | |
60 Neutral | $11.86B | 763.27 | 0.23% | 5.75% | 4.10% | -92.47% | |
54 Neutral | $4.50B | 788.30 | 0.71% | 5.05% | 5.12% | ― | |
52 Neutral | $415.13M | ― | -11.53% | 3.17% | -11.47% | -89.12% |